Global Cardiac Sutures Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Type (Absorbable Cardiac Sutures, Non-Absorbable Cardiac Sutures), By Material (Polypropylene, ePTFE (Expanded PTFE), Polyester, Polyglactin 910 (Vicryl), Nylon), By Application / Procedure (Coronary Artery Bypass Grafting (CABG), Valve Repair & Replacement, Aneurysm & Aortic Repair, Congenital Heart Defect Repair, Heart Transplantation & Assist Devices), By End User (Hospitals, Cardiac Specialty Centers, Ambulatory Surgery Centers, Academic & Research Institutes), By Region, By Company 2021-2031F 2021-2031F

Key Insights	Details
Forecast Period	2025 - 2031
Market Size (2025)	USD 1.58 Billion
CAGR (2026-2031)	7.16%
Fastest Growing Segment	Aneurysm repair and valve surgery
Largest Market	North America
Market Size (2031)	USD 2.39 Billion

Market Overview

The Global Cardiac Sutures Market is expected to grow from USD 1.58 Billion in 2025 to USD 2.39 Billion by 2031 at a 7.16% CAGR. Cardiac sutures are specialized medical devices utilized in cardiac surgeries to meticulously close incisions and facilitate the healing of heart tissue and surrounding vasculature. The global cardiac sutures market growth is primarily supported by the increasing prevalence of cardiovascular diseases worldwide, an aging global population requiring advanced cardiac care, and continuous advancements in surgical techniques, including minimally invasive procedures. According to the European Society of Cardiology's 2025 report, cardiovascular disease was associated with over 3 million deaths annually across its member countries in 2024, emphasizing the substantial demand for cardiac interventions.

However, a significant challenge impeding market expansion is the substantial cost associated with advanced cardiac surgeries and the highly specialized devices employed, alongside stringent and complex regulatory approval pathways that can delay market entry for innovative suture technologies.

Key Market Drivers

Rising Cardiovascular Disease Burden Sustains Cardiac Sutures Demand
The rising global prevalence of cardiovascular diseases significantly impacts the global cardiac sutures market by creating a persistent and increasing demand for cardiac interventions. As cardiovascular diseases (CVDs) continue to be a leading cause of morbidity and mortality worldwide, the necessity for surgical procedures requiring specialized sutures remains high. Globally, approximately 19.95 million people die from cardiovascular disease each year, with the total number of people living with some form of the disease having climbed to 643.11 million. This substantial patient pool directly translates into a sustained volume of cardiac surgeries, including coronary artery bypass grafting, valve repairs, and other complex procedures, all of which rely heavily on cardiac sutures for tissue approximation and wound closure. The growing burden of CVDs underscores the ongoing need for effective and reliable surgical solutions.

Advances in Suture Materials and Their Clinical Impact
Technological innovations in suture materials represent another crucial driving factor, as these advancements improve surgical outcomes and expand the utility of cardiac sutures. The development of advanced materials focuses on enhancing properties such as biocompatibility, tensile strength, and absorption profiles, tailoring sutures for specific cardiac applications. For instance, according to a study published on medRxiv in May 2025, novel absorbable sutures based on soluble collagen demonstrated higher mechanical strength in vivo compared to control synthetic polymer sutures, with no immune rejection or adverse events observed. Such innovations contribute to reduced post-surgical complications, improved healing, and faster patient recovery, which are critical considerations in cardiac care. Furthermore, cardiovascular disease remains the leading cause of death globally, responsible for an estimated 17.9 million deaths per year. This persistent global health challenge motivates continuous research and development into superior suture technologies, ensuring that surgeons have access to the most effective tools for delicate cardiac procedures.

Download Free Sample Report

Key Market Challenges

Economic Barriers Impede Cardiac Suture Market Growth
The substantial cost associated with advanced cardiac surgeries and the highly specialized devices employed significantly impedes the growth of the global cardiac sutures market. High procedural expenses, combined with the premium pricing of innovative surgical instruments and sutures, create considerable financial barriers for healthcare systems and individual patients. This economic burden can lead to restricted access to necessary cardiac interventions, particularly in regions with limited healthcare budgets or underdeveloped insurance coverage.

Financial Constraints Limit Surgeries and Market Expansion
This cost barrier directly curtails the volume of cardiac procedures performed, consequently reducing the demand for specialized cardiac sutures. According to the World Heart Federation's 2026 "World Heart Report on Congenital Heart Disease," over 90% of children in lower- and middle-income countries (LMICs) lack access to timely care for congenital heart disease, primarily because surgical costs frequently exceed household yearly income. Such profound financial constraints directly limit the number of cardiac surgeries undertaken, thereby hindering the overall expansion of the cardiac sutures market.

Key Market Trends

Growth of personalized, patient-specific sutures.
The global cardiac sutures market is significantly influenced by the development of customized and personalized suture solutions. This trend emphasizes tailoring sutures to individual patient anatomies and specific surgical requirements, moving beyond standardized products. Personalized solutions can optimize tissue approximation, minimize foreign body reaction, and enhance healing outcomes, particularly crucial in complex cardiac procedures. This focus on bespoke medical devices, while nascent for sutures, reflects a broader industry shift towards patient-specific care. For instance, according to news reported in June 2024, restor3d, a company focused on personalized orthopaedic implants, secured a $70 million Series A funding round for advancing innovations in 3D-printed implants, demonstrating significant investment in customized medical device technology that can influence related fields like cardiac sutures.

Adoption of automated, robotic-assisted suturing.
Another pivotal trend shaping the market is the emergence of automated suturing systems, often integrated with robotic-assisted surgical platforms. These systems aim to enhance precision, consistency, and efficiency in suturing, particularly valuable in minimally invasive cardiac surgeries where manual dexterity can be challenging. Automated suturing can reduce operative time, minimize surgeon fatigue, and potentially lower complication rates by ensuring uniform tension and knot placement. This technological advancement is evidenced by the rapid adoption of robotic surgical procedures; according to Intuitive Surgical's Annual Report 2023, published in January 2024, worldwide da Vinci procedures grew approximately 22% in 2023 compared to the prior year, highlighting a significant transition towards automated workflows in surgery.

Segmental Insights

Aneurysm Repair and Valve Surgery: Fastest-Growing Segment Driven by Aging Population and Rising CVD Incidence
The aneurysm repair and valve surgery segment is currently the fastest-growing area within the global cardiac sutures market. This accelerated expansion is primarily fueled by the increasing global incidence of cardiovascular diseases, which necessitates a rising volume of intricate cardiac interventions. A significant factor contributing to this trend is the expanding aging population, which is more prone to developing conditions requiring aneurysm repair and valve replacement procedures. Additionally, ongoing advancements in surgical techniques and the continuous development of specialized suture materials, engineered for delicate cardiac tissues, are crucial in enhancing the efficacy and safety of these critical operations. These combined elements underscore the consistent demand for advanced cardiac sutures in addressing life-threatening aortic and valvular conditions.

Regional Insights

North America Leads Cardiac Sutures Market: Infrastructure, Demand, and Regulatory Support
North America leads the global cardiac sutures market due to its highly developed healthcare infrastructure, which supports advanced cardiac surgical facilities and skilled medical professionals. A significant prevalence of cardiovascular diseases across the region drives consistent demand for cardiac interventions. Furthermore, a robust focus on research and development, coupled with a favorable regulatory environment established by bodies such as the U.S. Food and Drug Administration (FDA), accelerates innovation and product approvals. The presence of major industry players and substantial healthcare expenditure also contribute to the region's strong market position for advanced cardiac suture solutions.

Recent Developments

• In October 2024, Vivasure Medical announced initial positive results from its US IDE PATCH pivotal study for the PerQseal closure device system. This system is a sutureless, fully absorbable synthetic device developed for large-bore vessel punctures, serving as an alternative to traditional suture- or collagen-based closure devices. The PerQseal system aims to reduce vascular complications and simplify closure in various cardiovascular procedures, including transcatheter aortic valve implantation (TAVI). These positive study results indicated a promising advancement in cardiac access site management, directly influencing the scope of the cardiac sutures market by offering alternative closure solutions.
• In August 2024, DePuy Synthes, a Johnson & Johnson company, introduced the MatrixSTERNUM™ Fixation System. This innovative plate and screw fixation system was launched to enhance chest wall stability and secure the sternum following open-heart and other chest surgeries. The system aimed to provide stronger locking strength and faster chest fixation, offering a refined approach to post-cardiac surgery closure. Its design, featuring thinner, low-profile plates, sought to streamline procedures and provide surgeons with increased flexibility in managing patient needs within the broader cardiac surgery market, where secure closure methods are paramount.
• In June 2024, Corcym China and Sunflowers Medtech established a strategic partnership. This collaboration aimed for deep cooperation within the field of cardiac surgery, leveraging complementary strengths to foster innovation and pursue mutual benefits. The alliance signifies a joint effort to advance solutions in cardiac care. While Corcym is known for sutureless aortic valve technologies, this broad partnership in cardiac surgery indicates a collective commitment to developing comprehensive solutions that impact various aspects of the cardiac surgery market, including the materials and methods used for surgical closure.
• In 2024, Ethicon, a Johnson & Johnson MedTech business unit, launched significant advancements in its suture portfolio. These new suture offerings included enhanced absorbable and antimicrobial lines, designed to improve tissue handling and reduce complications during surgical procedures. Such innovations are crucial for various surgical disciplines, including cardiovascular surgery, by addressing clinical priorities such as infection reduction and optimizing wound closure. Ethicon's continuous investment in advanced suture technologies underscores its commitment to improving patient outcomes and contributing to the evolving landscape of the global cardiac sutures market.

Key Market Players

• Johnson & Johnson
• Medtronic plc
• B. Braun Melsungen AG
• Teleflex Incorporated
• W. L. Gore & Associates
• Ethicon (Johnson & Johnson)
• Medtronic
• B. Braun
• Teleflex
• W. L. Gore & Associates

By Type	By Material	By Application / Procedure	By End User	By Region
Absorbable Cardiac Sutures Non-Absorbable Cardiac Sutures	Polypropylene ePTFE (Expanded PTFE) Polyester Polyglactin 910 (Vicryl) Nylon	Coronary Artery Bypass Grafting (CABG) Valve Repair & Replacement Aneurysm & Aortic Repair Congenital Heart Defect Repair Heart Transplantation & Assist Devices	Hospitals Cardiac Specialty Centers Ambulatory Surgery Centers Academic & Research Institutes	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Cardiac Sutures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Cardiac Sutures Market, By Type:

• Absorbable Cardiac Sutures
• Non-Absorbable Cardiac Sutures

• Cardiac Sutures Market, By Material:

• Polypropylene
• ePTFE (Expanded PTFE)
• Polyester
• Polyglactin 910 (Vicryl)
• Nylon

• Cardiac Sutures Market, By Application / Procedure:

• Coronary Artery Bypass Grafting (CABG)
• Valve Repair & Replacement
• Aneurysm & Aortic Repair
• Congenital Heart Defect Repair
• Heart Transplantation & Assist Devices

• Cardiac Sutures Market, By End User:

• Hospitals
• Cardiac Specialty Centers
• Ambulatory Surgery Centers
• Academic & Research Institutes

• Cardiac Sutures Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE